This month’s healthcare and pharmaceutical coverage highlights how political decisions and emerging technologies are redefining access to care and public confidence in the system. From Trump’s initiatives on drug pricing, fertility access, and AI-driven cancer research to growing scrutiny of AI’s role in medical advice, the discussions reflect a sector balancing innovation with regulation and […]
